TrueMed is proud to announce that we delivered our non-additive authentication technology for PharmaLedger’s Anti-Counterfeiting use case.
PharmaLedger, a public-private project with 29 members under the Innovative Medicines Initiative (IMI), has successfully concluded its second year. The goal of the PharmaLedger is to provide a widely trusted platform that supports the design and adoption of blockchain-enabled healthcare solutions while accelerating delivery of innovation that benefits the entire ecosystem, from manufacturers to patients.
TrueMed is looking forward to continue its ongoing collaboration with PharmaLedger in making the world a safer place in 2022.
Read the full press release here.